Status:
UNKNOWN
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Lead Sponsor:
Aga Khan University
Collaborating Sponsors:
The George Institute
Conditions:
Cardiovascular Diseases
Cerebral Infarction
Eligibility:
All Genders
18-90 years
Brief Summary
We will evaluate an e\_Prescription intervention can be integrated into an electronic screening program, which together exploit: (i) reach - the adult population has 100% mobile phone ownership and 92...
Detailed Description
The goal of this pilot study is to demonstrate feasibility of a scalable , population-wide, approach to early detection and management of people at high-risk of CVD using electronic screening, referra...
Eligibility Criteria
Inclusion
- All adult (\>18 years) residents of Malir district
- Own a mobile phone
- Provide written informed consent are eligible to participate
Exclusion
- Not permanent residents of Malir district.
- A person who is decision impaired due to stroke, or aphasia or dementia .
- Serious cognitive deficits that impair the visualization or understanding of SMS, IVR and e\_prescription messages
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04082091
Start Date
September 1 2019
End Date
September 1 2020
Last Update
September 9 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.